Consonance Capital Partners, LP, a Delaware limited partnership (the “Adviser”), was formed in 2012 as a
limited liability company. In December 2014, the Adviser changed its form of organization from a limited
liability company to a limited partnership.
The Adviser provides discretionary investment advisory services solely to pooled investment vehicles and
co-investment vehicles organized as private investment funds (collectively, the “Funds”). The Funds are
private investment funds organized principally to invest in healthcare businesses. References to the Adviser
herein should be read to include affiliates of the Adviser, as applicable.
The Funds are:
• Consonance Private Equity, L.P., a Delaware limited partnership (the “Main Fund I”);
• Consonance Private Equity PV, L.P., a Delaware limited partnership (the “PV Fund I”);
• Consonance Private Equity AF, L.P., a Delaware limited partnership (the “Friends and Family
Feeder Fund I”);
• Consonance Private Equity II, L.P., a Delaware limited partnership (the “Main Fund II”);
• Consonance Private Equity PV, II, L.P., a Delaware limited partnership (the “PV Fund II”);
• Consonance Private Equity AF II, L.P., a Delaware limited partnership (the “Friends and Family
Feeder Fund II”);
• Consonance Bako Co-Invest Partners, L.P., a Delaware limited partnership (the “Bako co-invest”);
• Consonance II Priority Ambulance Co-Invest Partners, L.P., a Delaware limited partnership (the
“Priority co-invest”);
• Consonance II Embark Co-Invest Partners, L.P., a Delaware limited partnership (the “Embark co-
invest”);
• Consonance II Embark Co-Invest PV, L.P., a Delaware limited partnership (the “Embark PV co-
invest”);
• Oliver OPS Blocker LLC, a Delaware limited liability company (the “OPS Blocker”); and
• Oliver OPS Blocker PV, LLC, a Delaware limited liability company (the “OPS Blocker PV”)
Main Fund I, PV Fund I and Friends and Family Feeder Fund I are referred to collectively herein as “Fund
I”. Main Fund II, PV Fund II and Friends and Family Feeder Fund II are referred to collectively herein as
“Fund II”. Main Fund I and Main Fund II are referred to collectively herein as the “Main Funds,” PV Fund
I and PV Fund II are referred to collectively herein as the “PV Funds” and Friends and Family Feeder Fund
I and Friends and Family Feeder Fund I are referred to collectively herein as the “Friends and Family Feeder
Funds”. Bako co-invest, Priority co-invest, Embark co-invest and Embark PV co-invest are referred to
collectively herein as the “co-invest vehicles”. OPS Blocker and OPS Blocker PV are referred to
collectively herein as the “OPS vehicles”.
Consonance Private Equity GP, L.P., a Delaware limited partnership (the “Lower GP I”), serves as the
general partner of Fund I. Consonance Private Equity GP II, L.P., a Delaware limited partnership (the
“Lower GP II”), serves as the general partner of Fund II. It should also be noted that Consonance GP Capital
Feeder, L.P, a Delaware limited partnership (the “GP Capital Vehicle”), and Consonance GP Carry Feeder,
L.P., a Delaware limited partnership (the “GP Carry Vehicle”), are limited partners of the Lower GP I and
the Lower GP II. Certain affiliates of the Adviser are limited
partners or members of the GP Capital Vehicle
and the GP Carry Vehicle. Consonance Private Equity GP, LLC, a Delaware limited liability company (the
“Upper GP”), serves as the general partner for the Lower GP I, the Lower GP II, the GP Capital Vehicle
and the GP Carry Vehicle.
Consonance Bako Holdings GP, LLC, a Delaware limited liability company (“Bako GP”), serves as the
general partner of the Bako co-invest. Consonance II Priority Ambulance Holdings GP, LLC, a Delaware
limited liability company (“Priority GP”), serves as the general partner of the Priority co-invest. The Lower
GP II serves as the general partner of the Embark co-invest and Embark PV co-invest.
The Adviser is the investment adviser to the Funds, each a private investment fund that invests in private
equity investments in lower to middle market companies in high growth sectors of the healthcare industry
(the “Investments”). The Adviser will advise the Funds as to their investment strategy. This strategy
typically includes companies in the lower to middle market of the healthcare industry with revenues
between $20 and $150 million with respect to Fund I, and revenues between $25 and $500 million with
respect to Fund II.
The Funds’ investment objectives and/or parameters are set forth in more detail in the Funds’ governing
documents (the “Fund Documents”) provided to each investor.
The investment management services rendered to the Funds primarily consists of sourcing, structuring, and
negotiating investments and dispositions, monitoring the performance of Investments, and performing
certain administrative services. Generally, the Adviser does not tailor its advisory services to the individual
needs of investors, and investors may not impose restrictions on investing in certain securities or types of
investments. As applicable, the Fund Documents set forth the Funds’ investment strategy, including
guidelines regarding the types of securities or other assets the Fund will invest in and portfolio limits (if
any). However, from time to time, the general partner of a Fund enters into side letters or other similar
agreements with one or more investors that provide such investors with terms additional to or different from
those set forth in the Fund Documents.
Mitchell J. Blutt, MD, Benjamin B. Edmands, Stephen V. McKenna and Nancy-Ann DeParle are the
founding members (“Founders”) of the firm and serve on the investment committee of Fund I. The Founders
as well as Javier Starkand and Sean Breen serve on the investment committee of Fund II. Consonance
Capital Partners GP, LLC is the general partner of the Adviser. Mitchell J. Blutt, MD, Benjamin B.
Edmands, Stephen V. McKenna and Nancy-Ann DeParle are the principal owners of Consonance Capital
Partners GP, LLC.
The Adviser does not participate in wrap fee programs.
As of December 31, 2023, the Adviser managed approximately $2.24 billion of the Funds’ assets on a
discretionary basis. The Adviser does not currently manage any Fund assets on a non-discretionary basis.
The information provided herein about the investment advisory services provided by the Adviser is
qualified in its entirety by reference to the Fund Documents of the Funds.